Part 1 of this article compares Rithm Capital’s recent investment composition, leverage, hedging coverage ratio, quarterly BV, economic return (loss), and current valuation to 17 mREIT peers. Due to ...

An update from Gain Therapeutics ( ($GANX) ) is now available. On December 18, 2025, Gain Therapeutics reported exploratory endpoint data from ...

This is an important contribution that largely confirms prior evidence that word recognition - a cornerstone of development - improves across early childhood and is related to vocabulary growth. This ...

KELOWNA, BC / / December 30, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a ...

BENGALURU: India’s space programme is beginning to look beyond rockets and orbits to a quieter, less visible frontier: data ...

From 2020 to 2023, 1,754 decedents had coal workers' pneumoconiosis (CWP) listed on their death certificates, according to ...

KELOWNA, BC / ACCESS Newswire / December 30, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, provides the follo ...

Most big Australian charities are using commercial profiling to ask for the right amount of money at the right time. But it’s ...

This exploratory study in healthy young adults found that plasma sodium levels within the normal clinical range are ...

Varegacestat, an investigational gamma secretase inhibitor (GSI), delivered clinically meaningful improvements in efficacy outcomes vs placebo in patients with progressing desmoid tumors, according to ...

DehydraTECH-semaglutide reduced overall side effects by 48% as compared to Rybelsus® DehydraTECH-semaglutide reduced gastrointestinal side effects by 55% as compared to Rybelsus® Recent financings ...